Joining forces to find cure and therapies for EB
EB-ResNet is a network of EB patient organisations actively funding EB research and partnering to drive its translation to clinical benefit.
The network aims to provide EB research information for scientists, clinicians, patients and industry. All these stakeholders have to work closely together to achieve our overall objective: Find cure and therapies for people living with Epidermolysis Bullosa.
EB-ResNet is managing the funding of promising EB research projects worldwide on behalf of its members. Fundamental research up to preclinical and clinical trials are in the portfolio. Since the 1980ies research on Epidermolysis Bullosa is going on and a lot has been achieved. Now it is even more challenging as the focus is shifting to clinical translation. Join EB-ResNet, apply for funds, and share your experiences to build partnership for clinical translation.